Drug Shortage Report for INHIBACE PLUS

Last updated on 2021-10-19 History
Report ID 130792
Drug Identification Number 02181479
Brand name INHIBACE PLUS
Common or Proper name INHIBACE PLUS
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) CILAZAPRIL HYDROCHLOROTHIAZIDE
Strength(s) 5MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 28
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-01-18
Actual start date
Estimated end date 2021-09-30
Actual end date 2021-09-24
Shortage status Resolved
Updated date 2021-10-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-01-04 English Compare
v2 2021-01-04 French Compare
v3 2021-01-19 English Compare
v4 2021-08-10 English Compare
v5 2021-08-10 French Compare
v6 2021-09-02 English Compare
v7 2021-09-02 French Compare
v8 2021-10-19 English Compare
v9 2021-10-19 French Compare

Showing 1 to 9 of 9